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Abbreviations {#feb212651-sec-0001}
=============

**Aβ**, β‐amyloid

**AD**, Alzheimer\'s disease

**APP**, amyloid precursor protein

**CAA**, cerebral amyloid angiopathy

**Cygb**, cytoglobin

**Ets‐1**, V‐ets avian erythroblastosis virus E26 oncogene homolog 1

**Hif1**, hypoxia‐inducible factor 1

**Ngb**, neuroglobin

**REST**, RE1‐silencing transcription factor

**ROS**, reactive oxygen species

**SEM**, standard error of the mean

**Sp1**, specificity protein 1

**VEGF**, vascular endothelial growth factor

 {#feb212651-sec-0002}

Alzheimer\'s disease (AD) is a prevailing neurodegenerative disorder with a clinical representation of neuropsychiatric disturbances and a progressive cognitive deterioration [1](#feb212651-bib-0001){ref-type="ref"}. On the histopathological level, AD brains are typified by the emergence of insoluble neurofibrillary tangles and extracellular plaques [2](#feb212651-bib-0002){ref-type="ref"}. The main building blocks of these aggregates are hyperphosphorylated tau protein and amyloid precursor protein (APP)‐derived β‐amyloid (Aβ), respectively. However, a clear correlation between the level of senile plaque burden and the dementia state is lacking [2](#feb212651-bib-0002){ref-type="ref"}. This led to the study of soluble Aβ species which are now thought to be one of the toxic entities that drive neuronal dysregulation, culminating in widespread neurodegeneration [3](#feb212651-bib-0003){ref-type="ref"}. Aβ possesses a metal‐binding capacity, entailing the generation of reactive oxygen species (ROS) through Fenton and Fenton‐like chemistry [4](#feb212651-bib-0004){ref-type="ref"}. Knowing the Aβ burden to progressively accumulate, it may be no surprise that antioxidant mechanisms no longer meet with such requirements, initiating a runaway process through ROS‐related mitochondrial damage [4](#feb212651-bib-0004){ref-type="ref"}, [5](#feb212651-bib-0005){ref-type="ref"}.

Cytoglobin (Cygb) [6](#feb212651-bib-0006){ref-type="ref"} and neuroglobin (Ngb) [7](#feb212651-bib-0007){ref-type="ref"} are heme proteins of the globin family with a ROS‐scavenging potential [8](#feb212651-bib-0008){ref-type="ref"}. Where the involvement of Cygb in neuroprotection is largely unexplored, Ngb has been receiving much attention given its neuron‐specific localization [9](#feb212651-bib-0009){ref-type="ref"}. Upon oxygen and glucose deprivation, Ngb transcription is upregulated in SH‐SY5Y cells, which is associated with enhanced cell survival [8](#feb212651-bib-0008){ref-type="ref"}. Moreover, elevated Ngb levels not only attenuate cortical hypoxic--ischemic injury *in vivo* [10](#feb212651-bib-0010){ref-type="ref"}, but are implicated in AD as well. *In vitro* studies showed an increased resistance of Ngb‐overexpressing primary neurons [11](#feb212651-bib-0011){ref-type="ref"} and PC12 cells [12](#feb212651-bib-0012){ref-type="ref"} against Aβ~25‐35~‐induced neurotoxicity. Ngb also sequesters heme from Aβ‐heme complexes, entailing a possible role in reducing the oxidation of neurotransmitters like serotonin [13](#feb212651-bib-0013){ref-type="ref"}. Ngb interferes with Aβ production *in vivo*, reducing Aβ~1‐40~ and Aβ~1‐42~ levels in a double‐cross mouse model that overexpresses Ngb in an AD‐linked background with both the Swedish (K670N/M671L) and Indiana (V717F) mutation [11](#feb212651-bib-0011){ref-type="ref"}. In a clinical setting, however, Ngb has only been found to be upregulated in early and moderately advanced AD, while being reduced to baseline levels when the pathology progresses to more severe stages [14](#feb212651-bib-0014){ref-type="ref"}, [15](#feb212651-bib-0015){ref-type="ref"}.

Interestingly, many risk factors for dementia are linked to acute ischemic events and the impediment of cerebral perfusion, for example, smoking, hypertension, and diabetes mellitus [16](#feb212651-bib-0016){ref-type="ref"}, [17](#feb212651-bib-0017){ref-type="ref"}, [18](#feb212651-bib-0018){ref-type="ref"}. Brain infarcts have, in particular, been identified as important modifiers of the severity of AD clinical symptoms [19](#feb212651-bib-0019){ref-type="ref"}. Moreover, the prevalence of dementia increases from 57% to 88% [19](#feb212651-bib-0019){ref-type="ref"}. In addition, neuroimaging data revealed \~ 80% more dysregulation in the cerebral vascular system of late onset AD cases as compared to other pathogenic events as, for example, Aβ deposition and metabolic dysfunction [20](#feb212651-bib-0020){ref-type="ref"}. AD also shares features involving white matter changes, clinical symptoms, and pathophysiological markers with vascular dementia [21](#feb212651-bib-0021){ref-type="ref"}. With cerebral hypoperfusion generally foregoing neurodegeneration, some authors even suggested to classify AD as a vascular pathology [16](#feb212651-bib-0016){ref-type="ref"}. The detrimental effect lays in reduced brain Aβ clearance and its ensuing deposition in leptomeningeal and cerebral vessel walls as cerebral amyloid angiopathy (CAA) [22](#feb212651-bib-0022){ref-type="ref"}, which is observed in up to 90% of AD patients [23](#feb212651-bib-0023){ref-type="ref"}. Of note, sustained elevated ROS levels are a key mediator of CAA and microhemorrhages as well [24](#feb212651-bib-0024){ref-type="ref"}. Hence, given the additional strong link between globins and oxygen availability [25](#feb212651-bib-0025){ref-type="ref"}, we questioned whether hypoxia would impact Ngb expression in young APP23 mice to a similar extend as would vast Aβ pathology. Moreover, while functions of Cygb entail neuroprotection, for example, detoxification of ROS [8](#feb212651-bib-0008){ref-type="ref"}, [26](#feb212651-bib-0026){ref-type="ref"}, [27](#feb212651-bib-0027){ref-type="ref"}, its involvement in AD pathology remained to be elucidated. We, therefore, opted to study the alterations of Ngb and Cygb levels in APP23 mice in parallel.

Aging APP23 mice represent a valid phenocopy of human AD, with a strong Aβ pathology in the neocortex and hippocampal region, and CA1 neuronal loss reaching up to 25% in mice with a high Aβ aggregation load [28](#feb212651-bib-0028){ref-type="ref"}, [29](#feb212651-bib-0029){ref-type="ref"}. CAA initiates in 8‐month‐old APP23 mice as focal deposits in leptomeningeal vessels [23](#feb212651-bib-0023){ref-type="ref"}. The transgene---human APP with the Swedish double mutation (K670N/M671L)---is expressed sevenfold above endogenous APP levels and driven by the neuron‐specific murine Thy‐1.2 promoter [28](#feb212651-bib-0028){ref-type="ref"}.

The present study shows for the first time Cygb expression upregulation in normoxic cortices of 12‐month‐old APP23 mice. We further detected Ngb and Cygb transcription to be downregulated in Aβ‐overexpressing brains when the APP23 mice were subjected to an additional hypoxic insult. To further unravel the underlying mechanism, we studied RE‐1‐silencing transcription factor (REST/NRSF) expression levels, for which we identified a recognition site in the regulatory region of both globins. Ngb‐Cygb‐REST/NRSF expression correlations were detected mainly in the cortex. These findings provide evidence for the loss of globin‐linked neuroprotection to be linked to AD angiopathogenis, while raising the possibility of REST/NRSF being an upstream regulator together with hypoxia‐inducible factor 1 (Hif1).

Experimental procedure {#feb212651-sec-0003}
======================

Transgenic mouse model {#feb212651-sec-0004}
----------------------

Male transgenic APP23 mice were studied along with wild‐type control littermates at the age of 3, 6, and 12 months. The colony of experimental animals was maintained on a C57BL/6J background for at least 20 generations. All procedures were approved by the animal ethics committee of the University of Antwerp (reference number 2012‐26) and were compliant to the European Communities Council Directive on the protection of animals used for scientific purposes (2010/63/EU).

Hypoxia induction and reoxygenation {#feb212651-sec-0005}
-----------------------------------

Experimental groups of wild‐type or APP23 mice were either (i) housed for 48 h at a normoxic oxygen concentration of 21%, (ii) housed for 48 h in a hypoxic chamber with 7% oxygen (premixed gases: 7% O~2~, 93% N~2~) or (iii), after the exposure to hypoxic air, reoxygenated for 6 h under normoxic conditions, as previously described [30](#feb212651-bib-0030){ref-type="ref"}. Mice of group 2 were euthanized by cervical dislocation immediately upon removal from the hypoxic chamber.

RNA extraction and real‐time quantitative PCR {#feb212651-sec-0006}
---------------------------------------------

The frontal cortex and hippocampus of each mouse was collected, snap frozen in liquid nitrogen and further processed for total RNA. RNA was extracted, using TRIzol Reagent in conjunction with the PureLink RNA Mini Kit (Life Technologies, Gent, Belgium) according to the manufacturer\'s instructions. First‐strand cDNA synthesis was performed on 1 μg of total RNA (NanoDrop; Thermo Scientific, Gent, Belgium) with the GoScript Reverse Transcription System (Promega, Leiden, the Netherlands) and random primers (0.5 μg per reaction). Real‐time quantitative PCR was performed on a StepOnePlus system (Life Technologies), following a 2‐min incubation at 95 °C before proceeding to 40 cycles of 95 °C for 15 s and 60 °C for 1 min. Each real‐time PCR reaction comprised Power SYBR Green PCR Master Mix (Applied Biosystems, Halle, Belgium), 7.5 ng cDNA (RNA equivalents), and 150 n[m]{.smallcaps} of each primer: *GAPDH* (F‐AGGTCGGTGTGAACGGATTTG, R‐GGGGTCGTTGATGGCAACA), β*‐Actin* (F‐GGCTGTATTCCCCTCCATCG, R‐CCAGTTGGTAACAATGCCATGT), *B2M* (F‐GTATACTCACGCCACCCACC, R‐TGGGGGTGAATTCAGTGTGAG), *Pgk1* (F‐CTCCGCTTTCATGTAGAGGAAG, R‐GACATCTCCTAGTTTGGACAGTG), *Ngb* (F‐TACAATGGCCGCCAGTTCT, R‐TGGTCACTGCAGCATCAATCA), *Cygb* (F‐CCGCAGCCTACAAGGAAGTGG, R‐GGGAGCTGGGAGGGGTCTT), *Hif1* (F‐CGGCTCATAACCCATCAACT, R‐CAACGTGGAAGGTGCTTCA), *VEGF* (F‐GCCTCCCTCAGGGTTTCGG,R‐CGATGATGGCGTGGTGGTG), or *REST* (F‐CATGGCCTTAACCAACGACAT, R‐CGACCAGGTAATCGCAGCAG). The four used housekeeping genes (*GAPDH*, β*‐actin*,*B2M*, and *Pgk1*) were selected from a list of 10 reference targets, using geNorm in qBase+ (Version 3.0; Biogazelle, Gent, Belgium), and achieved a value *V* \< 0.15. Inter‐run calibration factors for each target were included to remove the run‐to‐run difference.

Immunohistochemistry {#feb212651-sec-0007}
--------------------

Coronal paraffin sections of brains were immunostained after microwave‐citrate (pH6) antigen retrieval for 10 min. Endogenous peroxidase activity within the tissue was blocked by incubation in 1% hydrogen peroxide in methanol for 30 min. After incubation in 1/25 normal goat serum and 1% bovine serum albumin in tris‐buffered saline to block nonspecific antibody binding, slides were stained overnight at 4 °C with primary antibody (1 : 500 Aβ ab2539, Abcam, Cambridge, UK; 1 : 100 Ngb 13499‐1‐AP, Protein Tech, Manchester, UK; 1 : 100 polyclonal Cygb [31](#feb212651-bib-0031){ref-type="ref"}). Subsequently, sections were incubated with 1 : 200 goat anti‐rabbit antibody (E0432; Dako, Leuven (Heverlee), Belgium) and further developed with the ABC Kit (Vector Laboratories, Peterborough, UK). Images were captured using an Olympus BX51 standard research fluorescence microscope (Olympus, Berchem, Belgium) equipped with an Olympus DP71 digital camera. Intensities of staining patterns were analyzed with [imagej]{.smallcaps} software (Fiji, Madison, WI, USA) and represented as optical densities; OD = log(max intensity/mean intensity).

Oxidative damage {#feb212651-sec-0008}
----------------

Total brain hemisphere lysate levels of malondialdehyde, an end product of lipid peroxidation, were studied using the lipid peroxidation (MDA) assay kit (Biovision, Milpitas, CA, USA) according to the manufacturer\'s instructions. The degree of lipid peroxidation was determined with reference to a malondialdehyde standard.

Data analysis {#feb212651-sec-0009}
-------------

The relative mean transcript values for the different conditions were calculated from normalized Cq values by reference to the mean of the baseline group, being the 3‐month‐old wild‐type mice that were housed under normoxic conditions. Calculations were performed with qBase+ (Version 3.0; BioGazelle). For immunohistochemistry data, the mean value of the cortex of the normoxic 3‐month‐old wild‐type mice was considered as the baseline. [graphpad prism]{.smallcaps} software (v5.0; San Diego, CA, USA) was used for graphing and statistical calculations. Statistical comparisons were performed using repeated measures analysis of variance (one‐way ANOVA) with Bonferroni\'s *post hoc* testing or Student\'s *t*‐testing, as indicated. *P*‐values below 0.05 were considered statistically significant. All data are depicted as the mean ± standard error of the mean (SEM).

Results {#feb212651-sec-0010}
=======

Aβ accretion and lipid peroxidation impact neuroprotective globin levels {#feb212651-sec-0011}
------------------------------------------------------------------------

To be able to follow the progression of pathology, we studied amyloid immunoreactivity in the cortex and hippocampus of APP23 mice and wild‐type control littermates at the age of 3, 6, and 12 months. The hippocampus shows higher Aβ protein staining intensities than the cortex and the cerebral Aβ load significantly increases only in the hippocampus (*t* = 4.174 Bonferroni, Fig. [1](#feb212651-fig-0001){ref-type="fig"}D). Given lipid peroxidation to be an early event in AD development and to be a major product of free radical‐mediated damage [32](#feb212651-bib-0032){ref-type="ref"}, we also quantified the levels of malondialdehyde, an end product of lipid peroxidation (Fig. [1](#feb212651-fig-0001){ref-type="fig"}E). The severity of both these inductors of cellular stress was correlated with the cortical and hippocampal transcription level of Cygb and Ngb (as comparison). APP23 mice of 12 months of age showed a 2.43 ± 0.21‐fold increase in Cygb expression in the frontal cortex, similar to the upsurge in Ngb transcription (Fig. [1](#feb212651-fig-0001){ref-type="fig"}A). Such an effect was not detected at the age of 3 and 6 months, that is, before the onset of plaque formation (Fig. [1](#feb212651-fig-0001){ref-type="fig"}D) and the kick‐in of oxidative stress (Fig. [1](#feb212651-fig-0001){ref-type="fig"}E). In contrast to the frontal cortex, none of the studied neuroprotective transcripts was significantly upregulated in the hippocampus (Fig. [1](#feb212651-fig-0001){ref-type="fig"}B).

![Influence of Aβ deposition and lipid peroxidation on increases in neuroprotective Ngb and Cygb. (A) Cortical and (B) hippocampal real‐time qPCR data of murine Cygb, Ngb, and VEGF expression levels of wild‐type mice (*n* = 4 per group) and APP23 mice (*n* = 4 per group) under normoxic conditions. (C) High‐power photomicrographs represent 20 × magnified pictures of Cygb immunohistochemistry. Optical densities relative to the 3‐month‐old wild‐type cortex are listed below. The scale bar represents 100 μm. Intensities show a disease progression‐dependent upregulation, that is, upon limited plaque burden (D, *n* ≥ 2) and in the presence of oxidative damage (E, *n* = 3). Data are depicted as the mean ± SEM. Statistical significance was tested using one‐way ANOVA with Bonferroni *post hoc* test; \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](FEB2-591-1321-g001){#feb212651-fig-0001}

Next, we studied the relationship between the globins' mRNA and protein levels, confirming that the Ngb protein staining pattern intensity increases at the onset of pathology (1.48 ± 0.19‐fold increase in cortices of 1‐year‐old APP23 mice, data not shown). However, we are the first too show that the optical density of the Cygb protein staining is also upregulated by 1.29 ± 0.02‐ and 1.13 ± 0.06‐fold in the cortex and hippocampus of 12‐month‐old APP23 mice, respectively. Of note, these elevations in Cygb protein levels correlate less with disease stage as those of Ngb, that is, they are not significantly different from those of the earlier 3 and 6 month time points (Fig. [1](#feb212651-fig-0001){ref-type="fig"}C).

Wild‐type animals show a more pronounced hypoxia‐counteracting transcriptional response {#feb212651-sec-0012}
---------------------------------------------------------------------------------------

Next, we sought to elucidate whether hypoxic events could underlie the previously observed downregulation of Ngb expression in the later stages of AD pathology [14](#feb212651-bib-0014){ref-type="ref"}, [15](#feb212651-bib-0015){ref-type="ref"}. Moreover, we aimed to examine if a similar impact of experimentally induced hypoxia could be detected on Cygb levels in limited Aβ‐stressed brains. Hence, mice of both genotypes and different ages were subjected to a general hypoxic insult of 7% oxygen for 48 h. Wild‐type mice showed the expected increase in globin expression ([10](#feb212651-bib-0010){ref-type="ref"}, [33](#feb212651-bib-0033){ref-type="ref"}, [34](#feb212651-bib-0034){ref-type="ref"}, Fig. [2](#feb212651-fig-0002){ref-type="fig"}A). In APP23 mice of 3‐ and 6‐months, however, Cygb and Ngb transcript levels stayed unaltered in comparison to the normoxic condition (Fig. [2](#feb212651-fig-0002){ref-type="fig"}A). Moreover, the globin expression levels were significantly lowered in the frontal cortex as compared to the normoxia group at 1 year (up to 0.62‐fold). Interestingly, mice of the same genotype but from different age groups did not display a difference in cerebral oxidative stress level upon the hypoxic insult, as can be deducted from the lipid peroxidation levels (Fig. [2](#feb212651-fig-0002){ref-type="fig"}D, ANOVA: *P* = 0.0572 for wild‐type mice and *P* = 0.1370 for APP23 mice). On the contrary, strong to very strong positive relationships were detected between VEGF and globin transcript levels across the different conditions (Table [1](#feb212651-tbl-0001){ref-type="table-wrap"}). These results indicate that the differences in globin transcription, that are perceived under hypoxia across the different age groups, are not driven by differences in lipid peroxidation levels, but rather can be attributed to other cellular dysregulations, for example, due to amyloid metabolism dysfunctions and VEGF signaling. Of note, although Cygb levels are lowered in the 1‐year‐old APP23 frontal cortices upon hypoxia induction, their levels are still retained above the level of 3‐month‐old, normoxic wild‐type mice (1.52‐fold, Fig. [2](#feb212651-fig-0002){ref-type="fig"}B). As for reinduction of globin expression after reoxygenation, the data of the hippocampus reveal a broader upregulation across the different conditions than the cortex (Fig. [2](#feb212651-fig-0002){ref-type="fig"}B).

![Withdrawal of Ngb expression upregulation upon hypoxia in APP23 brain. Cortical and hippocampal transcript (A,B) levels of murine Cygb and Ngb after (A) 48 h of hypoxia and (B) 48 h of hypoxia, followed by 6 h of reoxygenation. Data of wild‐type and APP23 mice (*n* = 4 per group) are depicted as the mean ± SEM and represent values relative to the age/genotype‐matched normoxic condition. Numbers above horizontal bars represent mean values relative to the baseline (values of 3‐month‐old, normoxic wild‐type mice). Significant differences with the baseline are defined as *P* \< 0.05, according to Student\'s *t*‐test and depicted above rectangles. Other statistical significances were tested using one‐way ANOVA with Bonferroni *post hoc* test; \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001. (C) Hippocampal expression levels of VEGF. (D) Quantitation of malondialdehyde (*n* = 3 per group), representing an end product of lipid peroxidation, in total brain hemisphere lysates. Given the lack of age‐dependent differences, the values of all wild‐type and APP23 mice were combined.](FEB2-591-1321-g002){#feb212651-fig-0002}

###### 

Pearson\'s correlation coefficients across the different oxygen availability conditions

  Correlation   VEGF: frontal cortex   VEGF: hippocampus                        
  ------------- ---------------------- ------------------- ------ ------ ------ ------
  Cygb          0.55                   0.64                0.62   0.65   0.47   0.71
  Ngb           0.38                   0.66                0.74   0.59   0.74   0.63

*r* ≥ +0.70, very strong positive relationship; *r* = +0.40 to +0.69, strong positive relationship; *r* = +0.30 to +0.39, moderate positive relationship; *r* = +0.20 to +0.29, weak positive relationship; *r* = +0.01 to +0.19, no or negligible relationship.

John Wiley & Sons, Ltd

In contrast to the transcriptional level where hypoxia reduces globin expression in APP23 mice, Ngb and Cygb protein levels are slightly elevated across all studied ages and in both the cortex and hippocampus of APP23 mice (Fig. [3](#feb212651-fig-0003){ref-type="fig"}A). The upregulation is paralleled with the lower degree of peroxidation as compared to the one of wild‐type mice (Fig. [2](#feb212651-fig-0002){ref-type="fig"}D). Of note, increases in protein staining after hypoxia and reoxygenation are higher for Cygb than for Ngb (Fig. [3](#feb212651-fig-0003){ref-type="fig"}A/B).

![Increased globin protein levels upon and after hypoxia in wild‐type and APP23 brain. Cortical and hippocampal protein (A,B) levels of murine Cygb and Ngb after (A) 48 h of hypoxia and (B) 48 h of hypoxia, followed by 6 h of reoxygenation. Data of wild‐type and APP23 mice (*n* ≥ 2 per group) are depicted as the mean ± SEM and represent values taken relative to the age/genotype‐matched normoxic condition. Numbers above horizontal bars represent mean values relative to the baseline, that is, the mean value of the cortex of the normoxic 3‐month‐old wild‐type mice. Significant differences compared to baseline values are defined as *P* \< 0.05, according to Student\'s *t*‐test and depicted above rectangles. Other statistical significances were tested using one‐way ANOVA with Bonferroni *post hoc* test; \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](FEB2-591-1321-g003){#feb212651-fig-0003}

Influence of RE1‐silencing transcription factor expression on globin transcription {#feb212651-sec-0013}
----------------------------------------------------------------------------------

To further unravel the underlying mechanism, we searched for REST interactions with globin regulatory sequences. First, the regions upstream of the *Ngb* and *Cygb* promotors were scanned for predicted REST‐binding sites using the MA0138.2 REST‐binding profile on jaspar.genereg.net (Fig. [4](#feb212651-fig-0004){ref-type="fig"}A). This search revealed not only a REST transcription factor‐binding site before the *Ngb* promotor (Fig. [4](#feb212651-fig-0004){ref-type="fig"}B, chr12:87110424‐87110444), but also in the *Cygb* regulatory region (Fig. [4](#feb212651-fig-0004){ref-type="fig"}B, Chr11:116653849‐116653869). Moreover, ChIP‐seq data on the UCSC Genome Browser (Human Feb. 2009 GRCh37/hg19 Assembly) show REST binding to the regulatory region upstream of the Ngb promotor in H1‐hESC cells. Hence, we analyzed the expression levels of REST across the different experimental groups. Given that REST activation can be both gene transcription inducing and downregulating, Fig. [4](#feb212651-fig-0004){ref-type="fig"} depicts the differences in REST expression levels between wild‐type and APP23 mice. REST expression does not differ between normoxic wild‐type and APP23 hippocampi across the different age groups (Fig. [4](#feb212651-fig-0004){ref-type="fig"}C). In the cortex, however, the difference in transcription between both genotypes increases with aging (Fig. [4](#feb212651-fig-0004){ref-type="fig"}C). This brain region‐specific expression alteration corresponds with the age‐dependent upsurge in cortical globin expression, which was not seen in the hippocampal area (Fig. [1](#feb212651-fig-0001){ref-type="fig"}A/B).

![Linking RE1‐Silencing Transcription factor to globins. (A) Profile of the REST transcription factor‐binding sequence (ID:MA0138.2 from the JASPAR CORE database). (B) Predicted REST‐binding sequences and their positions in the regulatory regions of the *Ngb* and *Cygb* genes. Mean differences ± SEM between wild‐type and APP23 expression levels of REST under (C) normoxia, (D) hypoxia, and (E) after reoxygenation (*n* ≥ 3 per group). (F) Mean fold change values of wild‐type and APP23 mice (*n* = 3--4 mice per group) relative to the genotype‐ and age‐matched normoxic condition.](FEB2-591-1321-g004){#feb212651-fig-0004}

After the hypoxic insult, cortical REST expression levels of wild‐type and APP23 mice differ most clearly at the 3‐ and 12‐month time points (Fig. [4](#feb212651-fig-0004){ref-type="fig"}D), which is also observed for globin transcription levels (Fig. [2](#feb212651-fig-0002){ref-type="fig"}A, capped lines between rectangles). The difference in wild‐type and APP23 hippocampal expression of REST diminishes with age (Fig. [4](#feb212651-fig-0004){ref-type="fig"}D). Such a trend is seen for hippocampal Cygb expression as well, with the difference in fold change lowering from 1.04 over 0.34 to 0.13 (Fig. [2](#feb212651-fig-0002){ref-type="fig"}A). Ngb expression during hypoxia appears to deviate from this pattern, with the difference between genotypes being highest at the 3‐ and 12‐month time points, as was the case for the cortical area (Fig. [2](#feb212651-fig-0002){ref-type="fig"}A, capped lines between rectangles). Nonetheless, hypoxic REST transcript levels are generally lowered relative to the age‐ and genotype‐matched normoxic levels in both brain areas from 6 months onwards (Fig. [4](#feb212651-fig-0004){ref-type="fig"}F). After reoxygenation, expression levels of REST and globins correlate less.

Discussion {#feb212651-sec-0014}
==========

Over the past 15 years, the genetics, structure, evolution, and biological functions of Cygb and Ngb have been intensively studied across the phylogenetic tree. In addition to the maintenance of cellular oxygen supply, a scala of physiological implications has been proposed for both globins, including the involvement in signal transduction, the detoxification of reactive oxygen or nitrogen species and the counteraction of cytochrome *c*‐induced apoptosis [25](#feb212651-bib-0025){ref-type="ref"}. Moreover, as mentioned in the introduction, transgenic overexpression of Ngb in the APP Swedish‐Indiana double‐mutation mouse model reduced the Aβ(1--40) load, restored somal microdomain distribution, and ameliorated performance in the Y‐maze [11](#feb212651-bib-0011){ref-type="ref"}. Despite its neuroprotective traits, Ngb transcription is downregulated to baseline levels in cases of severe AD pathology [14](#feb212651-bib-0014){ref-type="ref"}, [15](#feb212651-bib-0015){ref-type="ref"}. As later stage AD is characterized by a lowered oxygen availability due to CAA [16](#feb212651-bib-0016){ref-type="ref"}, [22](#feb212651-bib-0022){ref-type="ref"}, [23](#feb212651-bib-0023){ref-type="ref"}, we questioned whether whole‐body hypoxia as a secondary insult could likewise downregulate Ngb and Cygb expression in young APP23 mice.

Upregulated cellular Ngb levels in AD‐affected cells have been described before. In particular, Ngb protein levels in patients with early and moderately advanced AD were detected to be increased by 23% in the superior temporal lobes [15](#feb212651-bib-0015){ref-type="ref"}. Ngb immunoreactivity further revealed the elevations in the cerebral cortex to be localized to both the cytoplasm of cell bodies and extracellular plaque‐like structures [14](#feb212651-bib-0014){ref-type="ref"}. To the best of our knowledge, this paper is the first to report an upregulation of *Cygb* levels in 12‐month‐old, normoxic APP23 cortices. In contrast to the upregulated globin expression in the cortex, we detected no alterations in APP23 hippocampal Ngb and Cygb transcription rates. As a trend of increased VEGF expression was also noticed in the cortex, but not in hippocampus, the latter could be attributed to the positive correlation between both globins and VEGF, which we detected across all studied conditions. Our observation of increased neuroprotective VEGF levels to be brain region specific is in line with the literature, which describes VEGF involvement to comprise the cerebral cortex and cerebrospinal fluid [35](#feb212651-bib-0035){ref-type="ref"}. Hence, Ngb and Cygb involvement in AD pathology could be strongly linked to Hif1 and VEGF expression. It is, however, likely that a variety of different transcription factors and upstream signals together elicit the observed globin expression patterns.

Binding sequences for REST, also known as Neuron‐Restrictive Silencer Factor, have been identified before in the regulatory region of Ngb, using both rVista 2.0 [36](#feb212651-bib-0036){ref-type="ref"} and MSCAN [37](#feb212651-bib-0037){ref-type="ref"}. To the best of our knowledge, we are the first to identify a recognition sequence in the regulatory region of *Cygb* as well. REST expression is induced during normal brain aging and its activation generally entails neuroprotection by downregulating targets involved in cell death [38](#feb212651-bib-0038){ref-type="ref"}. However, transcription of *REST* is markedly reduced in AD‐affected neuronal populations [38](#feb212651-bib-0038){ref-type="ref"}, [39](#feb212651-bib-0039){ref-type="ref"}. Moreover, REST increases transcription of genes related to neurotransmission in the early stages of AD. In later stages, these genes are suppressed [38](#feb212651-bib-0038){ref-type="ref"}. Given the dual and opposing effects of REST, no consensus is reached yet on whether upregulated REST levels are protective or detrimental [40](#feb212651-bib-0040){ref-type="ref"}. Hence, we opted to focus on differences in transcription levels of REST between normoxic wild‐type and APP23 mice. In doing so, we detected altered expressions in frontal cortices of 1‐year‐old APP23 mice for Ngb, Cygb, and REST, while hippocampal levels of all three genes remained relatively unchanged as compared to the wild‐type levels. These findings strengthen the hypothesis of REST/NRSF regulating globin expression together with Hif1/VEGF along the AD pathology.

In advanced AD stages, Ngb transcript levels in the CA1 region of the hippocampus were reported to return to values found in healthy control subjects [14](#feb212651-bib-0014){ref-type="ref"}. In the present study, we identified a comparable decrease to baseline expression in 3‐, 6‐, and 12‐month‐old APP23 mice when they were subjected to whole‐body hypoxia. Based on our observations, we postulate the following two hypotheses: (i) the Ngb promotor activity is downregulated when a threshold degree of cellular damage/dysregulation is reached and/or (ii) hypoxia and vast amyloid aggregation pathology effectuate a convergent pathway that interferes with the activity of an inducer of Ngb expression. Interestingly, hypoxia induces the miR‐106b\~25 cluster that downregulates REST in LNCaP and PC3 prostate cancer cell lines [41](#feb212651-bib-0041){ref-type="ref"}. We identified REST expression levels to be decreased relative to age‐ and genotype‐matched normoxic levels, although this downregulation was only seen in animals aged ≥ 6 months. Hence, as similar for the normoxic groups, the globin expression patterns are more likely the result of a triad of upstream signals, for example, related to Hif1 as well.

In contrast to the downregulation of Ngb in hypoxic APP23 brains, Cygb transcript levels remain elevated relative to the normoxic condition. The reason as to why Cygb expression is able to overcome such negative regulation could be the confirmation of our previous finding of a strong positive relationship between Cygb and VEGF [34](#feb212651-bib-0034){ref-type="ref"}. VEGF was chosen over Hif1 as Hif1 is regulated to a large extent at the post‐mRNA level [42](#feb212651-bib-0042){ref-type="ref"}. The cross‐talk between Ngb and Hif1/VEGF, on the other hand, is indirect through the specificity protein 1 (Sp1) transcription factor [43](#feb212651-bib-0043){ref-type="ref"}. However, we also detected a generally lower transcriptional response of Cygb expression alteration in the 3‐month‐old APP23 mice as opposed to those of the 1‐year time point. It is possible that due to AD‐linked cellular dysregulations, some kind of prior history of hypoxia (e.g., amyloid angiopathy) is required to trigger an upregulation in Cygb transcription. Such phenomenon could be similar to hypoxic preconditioning in which sublethal stress endorses (neuro)protective actions against acute injuries [44](#feb212651-bib-0044){ref-type="ref"}. The latter would be consistent with the Cygb promotor containing a V‐ets avian erythroblastosis virus E26 oncogene homolog 1 (Ets‐1) site [45](#feb212651-bib-0045){ref-type="ref"}. Ets‐1 is upregulated in cortices and hippocampi of AD patients, surmounted by Ets‐1 being strongly connected with angiogenic markers as VEGF [46](#feb212651-bib-0046){ref-type="ref"}.

In contrast to their transcript levels, the Ngb and Cygb protein levels in APP23 mice are all elevated after hypoxia and reoxygenation, thereby paralleling lipid peroxidation levels. Sustained protein levels could be attributed to Aβ oligomers impairing the proteasome and, hence, favoring a low protein turnover. Decreased proteasome functioning already occurs in prepathological disease stages in 3xTg‐AD mice [47](#feb212651-bib-0047){ref-type="ref"}. In APP23 mice, we recently detected an age‐genotype interaction effect on expression levels of genes enriched for modules of the lysosomal pathway, the degradation by proteases and the proteasome (e.g., Psmb9) [48](#feb212651-bib-0048){ref-type="ref"}. The decrease in rodent proteasome activity is a good phenocopy of the human situation in which proteasomal inhibition reaches up to 48% in AD brains [49](#feb212651-bib-0049){ref-type="ref"}. Furthermore, AD is not only characterized by a lysosomal blockage caused by Aβ, but cathepsin D transcript and protein levels are both reduced in AD‐affected cells as well [50](#feb212651-bib-0050){ref-type="ref"}, [51](#feb212651-bib-0051){ref-type="ref"}. As a consequence, globin‐linked neuroprotection could be extended beyond stages with reduced transcript levels. We do not exclude that post‐transcriptional regulations take into effect, hence impacting globin protein levels as well. In particular, a discrepancy between Cygb/Ngb transcript and protein levels was observed before [52](#feb212651-bib-0052){ref-type="ref"}, [53](#feb212651-bib-0053){ref-type="ref"}. Moreover, the involvement of Cygb in AD pathology had not yet been described, with the exception of it being present in eosinophilic cytoplasmic inclusions [54](#feb212651-bib-0054){ref-type="ref"}. Ngb immunoreactivity in AD cortices also exhibits a punctate distribution outside cell bodies, in addition to being elevated within neurons [14](#feb212651-bib-0014){ref-type="ref"}. Hence, it should not be excluded that Cygb and Ngb become (in part) physiologically unavailable in later stages of AD pathology.

A combination of reduced protein turnover, REST activation patterns and Hif1 activation could underlie our observations, leading to a novel hypothesis concerning Ngb (post)transcriptional regulation as depicted in Fig. [5](#feb212651-fig-0005){ref-type="fig"}. Even though such a pathway seems to emerge from our obtained data, additional experiments will be required to fully support this hypothesis. Since REST has the potency to be both activating and inhibiting with regard to gene expression [38](#feb212651-bib-0038){ref-type="ref"}, [40](#feb212651-bib-0040){ref-type="ref"}, [55](#feb212651-bib-0055){ref-type="ref"}, its influence on globin expression requires further research to allow absolute expression levels of REST to be correlated with globin transcription. The latter would also require data on REST protein levels and knowledge on its subcellular localization. In cases of aggregation pathologies, for example, AD and frontotemporal lobar degeneration, REST appears trapped in cytoplasmic inclusions [38](#feb212651-bib-0038){ref-type="ref"}.

![Scheme summarizing the proposed hypothesis for Ngb (post)transcriptional regulation. Hypoxia‐induced Ngb expression is hypothesized to work through the HIF1‐Sp1‐Ngb axis as the Ngb promotor lacks a direct‐binding site for HIF1, but contains a Sp1‐binding GC‐box [36](#feb212651-bib-0036){ref-type="ref"}, [43](#feb212651-bib-0043){ref-type="ref"}. Moreover, Sp1 is known to participate downstream of HIF1 in sequential gene activation upon cerebral ischemia [56](#feb212651-bib-0056){ref-type="ref"}. Another transcription factor regulating Ngb expression is REST. Its upregulation is paralleled with aging, largely ascribed to cell nonautonomous Wnt signaling. However, REST can get trapped with pathological misfolded proteins, including Aβ, losing its nuclear levels and downstream neuroprotective actions [38](#feb212651-bib-0038){ref-type="ref"}. REST is also downregulated by hypoxia‐induced miRNAs [41](#feb212651-bib-0041){ref-type="ref"}. Hence, we hypothesize the co‐occurrence of both nuclear REST‐depleting events in hypoxic APP23 brains to outweigh Ngb expression‐inducing signals. Of note, Aβ oligomers impair proteasome function as from prepathological disease stages, that is, 3 months in transgenic mice [47](#feb212651-bib-0047){ref-type="ref"}. The latter makes us postulate that the discrepancy between transcript and protein levels in hypoxic APP23 brains is caused by a blocked proteasomal function, favoring a low protein turnover. If still physiologically available, the sustained Ngb levels could entail a prolonged neuroprotective action being carried out. CREB, cAMP response element‐binding protein; Hif1, hypoxia‐inducible factor 1; REST, RE1‐silencing transcription factor; ROS, reactive oxygen species; SP1, specificity protein 1.](FEB2-591-1321-g005){#feb212651-fig-0005}

In conclusion, our data point for the first time to a possible widening of the neuroprotective traits of Cygb to AD pathology and to Cygb being strongly associated with VEGF angiopathogenic alterations. Moreover, we showed that hypoxia up‐ and downregulates globin expression in young, wild‐type, and APP23 mice, respectively. Given the genotype‐ and brain region‐specific expression of REST, we hypothesize REST activation patterns to also contribute to globin expression alterations.
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